by matt | Mar 10, 2023 | Emails
Now Approved: SYFOVRE™ (pegcetacoplan injection) Email content sponsored by Apellis Pharmaceuticals, Inc. Email content sponsored by Apellis Pharmaceuticals, Inc. NOW APPROVED:The first and only treatment proven to slow lesion growth rate in GA secondary to...
by matt | Mar 10, 2023 | Emails
Now Available: Orenitram® Titration Kits for Simplified Dosing Orenitram Titration Kits for Simplified Dosing 96 --> Orenitram Titration Kits for Simplified Dosing We are pleased to announce the availability of the Orenitram Titration Kit, designed to...
by matt | Mar 10, 2023 | Emails
Announcing a price change for HEPLISAV-B®, {Hepatitis B Vaccine (Recombinant), Adjuvanted} This message is being sent by www.BuyandBill.com on behalf of Dynavax Technologies Effective March 1, 2023 the pricing of HEPLISAV-B® will change as outlined...
by matt | Mar 10, 2023 | Emails
New Treatment Option Available For Ultra-rare LSD We are pleased to announce the recent FDA approval of Lamzede® (velmanase alfa-tycv); a recombinant human lysosomal alpha-mannosidase indicated for the treatment of non-central nervous system manifestations of...
by matt | Mar 10, 2023 | Emails
J1932, injection, lanreotide, (Cipla), has received Pass-Through Status G from The Centers for Medicare and Medicaid (CMS) From: BuyandBill.com <info@buyandbill.com> To: [customer]Subject: J1932, Lanreotide Injection (Cipla) has received...
by matt | Mar 9, 2023 | Emails
Effective January 1, 2023: J1954 The unique HCPCS code for Cipla USA's LEUPROLIDE ACETATE INJECTION DEPOT (Leuprolide Acetate for Depot Suspension) Effective January 1, 2023: J1954, injection, leuprolide, (Lutrate), 7.5 mg, is available for all sites of care.J1954...
